Menu
Fechar
HRS4R
Vull donar
Firma
ALEXANDRE AGUILERA-LUQUE
Posició
Investigadors/es Col·laboradors/es
Investigadors/es Col·laboradors/es
Projectes
Publicacions

Projectes

Endocrinologia pediàtrica

A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS)

Codi oficial: ICI21/00005 Data inici: 01/01/2022 Data fi: 31/12/2025 Investigador/a principal: ABEL LÓPEZ BERMEJO Organisme finançador: INSTITUTO DE SALUD CARLOS III
Nutrició, Eumetabolisme i Salut

Involvement of the gut microbiota-brain cross talk in the loss of eating control

Codi oficial: HR22-00737 Data inici: 01/10/2022 Data fi: 30/09/2025 Investigador/a principal: ANNA CASTELLS NOBAU, JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUNDACIÓN BANCARIA LA CAIXA
Endocrinologia pediàtrica

Novel insights into the pathogenesis of Polycystic Ovary Syndrome using a genetic 'model: identification of potential biomarkers for early diagnosis in humans

Codi oficial: 36/C/2024 Data inici: 10/03/2025 Data fi: 10/03/2028 Investigador/a principal: ABEL LÓPEZ BERMEJO Organisme finançador: FUNDACIO LA MARATO TV3

Publicacions

Sojo-Vega L, Recasens M, Martínez J, Aguilera A, Ayala M, Admetlla N, Pellicer P, Blay C, Fabregat B, Esteve-Serra M, Riera L, Barahona R, Xifra G, Esteve E, Biarnés J, Pérez D, Gifre G, Mauri S, Costa E, Wos M, Buxó M, Fernández-Balsells M

Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes.

CARDIOVASCULAR DIABETOLOGY, 2024, 23, 366-366 dx.doi.org/10.1186/s12933-024-02455-0
Sojo L, Santos-González E, Riera L, Aguilera A, Barahona R, Pellicer P, Buxó M, Mayneris-Perxachs J, Fernandez-Balsells M, Fernández-Real JM

Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes

Antioxidants, 2023, 12 dx.doi.org/10.3390/antiox12051132
Cornejo-Pareja IM, Gómez-Pérez AM, Fernández-García JC, Barahona San Millan R, Aguilera Luque A, de Hollanda A, Jiménez A, Jimenez-Murcia S, Munguia L, Ortega E, Fernandez-Aranda F, Fernández Real JM, Tinahones F

Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease

EUROPEAN EATING DISORDERS REVIEW, 2020, 28, 799-815 dx.doi.org/10.1002/erv.2770

Formulari de contacte

Coneix l’IDIBGI!

 menu